New York Life Investment Management LLC Sells 6,478 Shares of Lam Research Corporation $LRCX

New York Life Investment Management LLC decreased its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 3.4% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 185,780 shares of the semiconductor company’s stock after selling 6,478 shares during the quarter. New York Life Investment Management LLC’s holdings in Lam Research were worth $24,876,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in LRCX. RFG Advisory LLC grew its stake in shares of Lam Research by 86.8% in the third quarter. RFG Advisory LLC now owns 14,131 shares of the semiconductor company’s stock valued at $1,892,000 after buying an additional 6,567 shares in the last quarter. Fielder Capital Group LLC lifted its stake in Lam Research by 3.6% in the third quarter. Fielder Capital Group LLC now owns 2,353 shares of the semiconductor company’s stock valued at $315,000 after acquiring an additional 81 shares during the last quarter. Canvas Wealth Advisors LLC grew its position in shares of Lam Research by 6.9% in the 3rd quarter. Canvas Wealth Advisors LLC now owns 2,438 shares of the semiconductor company’s stock valued at $355,000 after acquiring an additional 157 shares during the period. Caliber Wealth Management LLC KS bought a new position in shares of Lam Research in the 3rd quarter valued at about $256,000. Finally, Plato Investment Management Ltd increased its stake in shares of Lam Research by 1.9% during the 3rd quarter. Plato Investment Management Ltd now owns 50,308 shares of the semiconductor company’s stock worth $6,685,000 after purchasing an additional 930 shares during the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.

Insider Buying and Selling at Lam Research

In related news, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.31% of the company’s stock.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam announced a strategic alliance with CEA‑Leti and an internal leadership shift aimed at accelerating AI‑equipment development — investors see this as direct exposure to faster AI capex cycles. Lam Research Targets AI Growth With CEA Leti Deal And Leadership Shift
• Positive Sentiment: Celebrity investor/TV host Jim Cramer publicly endorsed adding LRCX to portfolios, raising retail/institutional interest and trading flows. Lam Research (LRCX) Is the Future, Says Jim Cramer
• Positive Sentiment: Argus and other analysts lifted price targets (Argus to $280) and the sell‑side average implies roughly 30% upside — upgrades and higher targets support buying interest. Argus Increases Lam Research Price Target to $280.00
• Positive Sentiment: Lam declared a $0.26 quarterly dividend (0.5% yield) — modest cash return but signals board confidence in cash flow and capital allocation. Lam Research Corporation Declares Quarterly Dividend
• Neutral Sentiment: Zacks and other screens highlight LRCX as a momentum pick amid recent market weakness — this flags participation from quant/momentum funds but also exposes the stock to volatility in a tech selloff. 3 Momentum Anomaly Stocks to Buy as Tech Rout Spooks Markets
• Neutral Sentiment: Company announced a board addition and COO transition — governance/leadership updates that deserve monitoring but aren’t an immediate revenue driver. Lam Research Announces Board Addition and COO Transition
• Negative Sentiment: Shares had a sharp pullback earlier in the week (noted as “down 10% in two days”), reflecting broader tech/crypto volatility — that recent selling created a short-term risk that some traders are buying into. Down 10 In Two Days, Is Lam Research A Good Buy?

Lam Research Stock Up 8.3%

NASDAQ LRCX opened at $231.01 on Monday. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. The company has a market cap of $288.48 billion, a price-to-earnings ratio of 47.34, a PEG ratio of 2.49 and a beta of 1.78. The company has a 50 day moving average of $194.38 and a 200-day moving average of $151.05. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $251.87.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. The firm had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The company’s revenue was up 22.1% on a year-over-year basis. During the same quarter last year, the company earned $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, equities research analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be given a $0.26 dividend. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. Lam Research’s payout ratio is presently 21.31%.

Analyst Upgrades and Downgrades

LRCX has been the subject of several recent analyst reports. Oppenheimer reiterated an “outperform” rating and issued a $265.00 target price on shares of Lam Research in a research note on Thursday, January 29th. Bank of America lifted their target price on Lam Research from $195.00 to $245.00 and gave the stock a “buy” rating in a research note on Tuesday, January 13th. Wells Fargo & Company increased their price target on Lam Research from $250.00 to $290.00 and gave the company an “overweight” rating in a research note on Thursday, January 29th. Wall Street Zen downgraded Lam Research from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Finally, B. Riley Financial reiterated a “buy” rating on shares of Lam Research in a report on Thursday, January 15th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $244.57.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.